Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;49(9):1306-1320.
doi: 10.1002/eji.201848056. Epub 2019 Jul 3.

Current perspectives on the interleukin-1 family as targets for inflammatory disease

Yasmina E Hernandez-Santana  1   2 , Eirini Giannoudaki  1   2 , Gemma Leon  1   2 , Margaret B Lucitt  3 , Patrick T Walsh  1   2
Affiliations
Free article
Review

Current perspectives on the interleukin-1 family as targets for inflammatory disease

Yasmina E Hernandez-Santana et al. Eur J Immunol. 2019 Sep.
Free article

Abstract

Since the first description of interleukin-1 (IL-1) and the genesis of the field of cytokine biology, the understanding of how IL-1 and related cytokines play central orchestrating roles in the inflammatory response has been an area of intense investigation. As a consequence of these endeavours, specific strategies have been developed to target the function of the IL-1 family in human disease realizing significant impacts for patients. While the most significant advances to date have been associated with inhibition of the prototypical family members IL-1α/β, approaches to target more recently identified family members such as IL-18, IL-33 and the IL-36 subfamily are now beginning to come to fruition. This review summarizes current knowledge surrounding the roles of the IL-1 family in human disease and describes the rationale and strategies which have been developed to target these cytokines to inhibit the pathogenesis of a wide range of diseases in which inflammation plays a centrally important role.

Keywords: Canakinumab; Inflammation; Inflammatory disease; Interleukin-1 family; Therapy.

PubMed Disclaimer

References

    1. Dinarello, C. A., Renfer, L. and Wolff, S. M., Human leukocytic pyrogen: purification and development of a radioimmunoassay. Proc. Natl. Acad. Sci. U. S. A 1977. 74: 4624-4627.
    1. Garlanda, C., Dinarello, C. A. and Mantovani, A., The interleukin-1 family: back to the future. Immunity 2013. 39: 1003-1018.
    1. Dinarello, C. A., IL-1: discoveries, controversies and future directions. Eur. J. Immunol. 2010. 40: 599-606.
    1. Boraschi, D., Italiani, P., Weil, S. and Martin, M. U., The family of the interleukin-1 receptors. Immunol. Rev. 2018. 281: 197-232.
    1. Dinarello, C. A., Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity. Immunol. Rev. 2018. 281: 5-7.

Publication types

LinkOut - more resources